Selexipag – Cardiology MCQ Selexipag is a: IP receptor antagonist Beta 3 receptor agonist Beta 3 receptor antagonist IP receptor agonist Click here for the correct answer
Pathways in pathogenesis of PAH – Cardiology MCQ – Answer Which of the following is NOT a pathway involved in the pathogenesis of pulmonary arterial hypertension (PAH)? Correct
Pathways in pathogenesis of PAH – Cardiology MCQ Which of the following is NOT a pathway involved in the pathogenesis of pulmonary arterial hypertension (PAH)? Endothelin pathway Nitric
Ventricular trigeminy Click here for a larger image Striking feature in the ECG is the presence of frequent bizarre wide QRS complexes. These wide QRS complexes are not
Predictors of heart failure in diabetes mellitus Patients with diabetes mellitus are more prone to develop heart failure than others. Important features of diabetes mellitus associated with the
Cornell voltage criteria for LVH In Cornell voltage criteria for left ventricular hypertrophy, S wave in V3 is added to R wave in aVL. Left ventricular hypertrophy as
Drug eluting stent vs drug coated balloon in primary PCI Paclitaxel coated balloon angioplasty was compared with drug eluting stent in acute ST elevation myocardial Infarction (STEMI) in
Ultrathin strut drug eluting stents for small vessel disease Implantation of stents in small vessels is often avoided due to the risk of adverse events like stent thrombosis
What are the histological processes in HCM? Four histological processes in hypertrophic cardiomyopathy (HCM): Myocyte hypertrophy Myocyte and myofibrillar disarray Small vessel disease Fibrosis Reference McKenna WJ, Moon
Assessing SCD risk in HCM by CMR Sudden cardiac death (SCD) is one of the dreaded complications of hypertrophic cardiomyopathy (HCM) and predicting it is always challenging. Clinical